First, a growing body of evidence suggested that increased plasma SDF-1 levels can promote insulin resistance and diabetic kidney disease [12–14, 27], which were reported to be significantly associated with recurrent stroke and poor functional outcomes after ischemic stroke [30, 31]. This evidence concerns the gene CXCL12 and stroke disorder.